PresentationBrian McNamaraCEO & Executive Director Hello, and welcome to our full year results presentation. 2025 was an important year for Haleon, and we made good progress against our 3 strategic priorities: first, delivering competitive growth in a challenging environment; second, unlocking productivity gains; and third, embedding an agile performance-focused culture. In terms of growth, in 2025, we delivered 3% organic sales growth, which is lower than our medium-term guidance of 4% to 6%. That was prim ...

Haleon (NYSE:HLN) H2 2025 Earnings call February 25, 2026 02:00 AM ET Company ParticipantsBrian McNamara - CEO and Executive DirectorDawn Allen - CFO and Executive DirectorBrian McNamaraHello, and welcome to our full year results presentation. 2025 was an important year for Haleon, and we made good progress against our three strategic priorities. First, delivering competitive growth in a challenging environment. Second, unlocking productivity gains. Third, embedding an agile, performance-focused culture. In ...

Haleon (NYSE:HLN) H2 2025 Earnings call February 25, 2026 02:00 AM ET Company ParticipantsBrian McNamara - CEO and Executive DirectorDawn Allen - CFO and Executive DirectorBrian McNamaraHello, and welcome to our full year results presentation. 2025 was an important year for Haleon, and we made good progress against our three strategic priorities. First, delivering competitive growth in a challenging environment. Second, unlocking productivity gains. Third, embedding an agile, performance-focused culture. In ...

Haleon (NYSE:HLN) H2 2025 Earnings call February 25, 2026 02:00 AM ET Speaker0Hello, and welcome to our full year results presentation. 2025 was an important year for Haleon, and we made good progress against our three strategic priorities. First, delivering competitive growth in a challenging environment. Second, unlocking productivity gains. Third, embedding an agile, performance-focused culture. In terms of growth, in 2025, we delivered 3% organic sales growth, which is lower than our medium-term guidanc ...

Group 1 - Haleon has appointed Carl Haney as Chief Research & Development Officer, effective August 1, 2025, following Franck Riot's departure after six years [1][2] - Carl Haney brings 13 years of experience from Estée Lauder and over 20 years from Procter & Gamble, focusing on innovation and R&D in consumer businesses [1][2] - The CEO of Haleon, Brian McNamara, expressed confidence in Haney's ability to drive transformative innovation and contribute to the company's new "Win as One" strategy [2][3] Group 2 - Franck Riot's contributions to Haleon were acknowledged, particularly in advancing the innovation agenda during the company's transition [3] - Carl Haney expressed enthusiasm about joining Haleon at a pivotal time, emphasizing the importance of R&D in achieving the company's goals of enhancing everyday health [3] - Haleon is positioned as a global leader in consumer health, with a diverse product portfolio across six major categories, including Oral Health and Pain Relief [4]